tadalafil tablet film coated
1 INDICATIONS AND USAGE Tadalafil tablets are a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of: erectile dysfunction (ED) ( 1.1 ) the signs and symptoms of benign prostatic hyperplasia (BPH) ( 1.2 ) ED and the signs and symptoms of BPH (ED/BPH) ( 1.3 ) If tadalafil tablets are used with finasteride to initiate BPH treatment, such use is recommended for up to 26 weeks ( 1.4 ). 1.1 erectile dysfunction Tadalafil tablets are indicated for the treatment of erectile dysfunction (ED). 1.2 benign prostatic hyperplasia Tadalafil tablets are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). 1.3 erectile dysfunction and benign prostatic hyperplasia Tadalafil tablets are indicated for the treatment of ED and the signs and symptoms of BPH (ED/BPH). 1.4 Limitation of Use If tadalafil tablets are used with finasteride to initiate BPH treatment, such use is recommended for up to 26 weeks because the incremental benefit of tadalafil tablets decreases from 4 weeks until 26 weeks, and the incremental benefit of tadalafil tablets beyond 26 weeks is unknown [see Clinical Studies ( 14.3 )].
teva pharmaceuticals usa, inc.
OVAL YELLOW Teva 3019
Teva 3019 OVAL YELLOW
Related Pills
tadalafil tablet 10 mg film coated
teva pharmaceuticals usa, inc.
tadalafil table 2.5 mg film coated
teva pharmaceuticals usa, inc.
tadalafil tablet film coated
teva pharmaceuticals usa, inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied
TADALAFIL tablets, USP are available as follows: 2.5 mg: light yellow, round, film-coated tablets, debossed with “TEVA” on one side of the tablet and with “3016” on the other side, in the following package sizes: Bottles of 30 (NDC 0093-3016-56) Unit-Dose Boxes of 30 (2 cards of 15 tablets) (NDC 0093-3016-65) 5 mg: yellow, round, film-coated tablets, debossed with “TEVA” on one side of the tablet and with “3017” on the other side, in the following package sizes: Bottles of 30 (NDC 0093-3017-56) Unit-Dose Boxes of 30 (2 cards of 15 tablets) (NDC 0093-3017-65) 10 mg: yellow, oval-shaped, film-coated tablets, debossed with “TEVA” on one side of the tablet and with “3018” on the other side, in bottles of 30 (NDC 0093-3018-56). 20 mg: yellow, oval-shaped, film-coated tablets, debossed with “TEVA” on one side of the tablet and with “3019” on the other side, in bottles of 30 (NDC 0093-3019-56). 16.2 Storage Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Keep this and all medications out of the reach of children.
More pills like OVAL Teva 3019